Sunlant is a leading brand in the field of biotechnology, specializing in the development and production of high-throughput protein microarray detection products. Established in 2007, Sunlant is based in the high-tech district of Wuxi, Jiangsu Province. The company has made significant contributions to the industrialization of automatic biological chip analyzers and supporting reagents in China.

Sunlant has undertaken two projects under the Ministry of Science and Technology's 863 program, and has been recognized as a national high-tech enterprise, a provincial engineering research center, and a provincial enterprise technology center. With a strong focus on research and development, Sunlant has built multiple technical platforms, enabling the production of a wide range of diagnostic products for areas such as oncology, cardiovascular diseases, autoimmune disorders, inflammation, and infectious diseases. Their products are widely used in various medical fields, including primary healthcare, emergency care, clinical diagnostics, epidemic monitoring, and personal health management.

With a team of experts in research, production, marketing, and after-sales services, Sunlant is committed to providing comprehensive clinical diagnostic solutions for medical institutions. Their mission is to continuously innovate and develop superior products, while prioritizing user experience and improving the quality of life and health for a wider population